glp-1 amgen Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond 2025’s Breakthrough GLP-1 Obesity Treatments:

The MHRA has approved specific GLP-1 receptor agonists for weight management (Wegovy and Saxenda) in individuals with a body mass index (BMI) of 30 kg/m or above, or 27 kg/m with weight-related comorbidities, while others are approved only for glycaemic control in type 2 diabetes

Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling

One drink can feel like several, and the risks go beyond just feeling tipsy

Tang, S

A) Belle Vies Medically Assisted Weight Management Program is designed for individuals who are committed to a healthy diet and exercise routine but need additional support to reach their ideal weight